Literature DB >> 16055435

Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21.

Motonori Nakagawa1, Jose Luis Oliva, Devashish Kothapalli, Alaina Fournier, Richard K Assoian, Marcelo G Kazanietz.   

Abstract

Although protein kinase C (PKC) has been widely implicated in the positive and negative control of proliferation, the underlying cell cycle mechanisms regulated by individual PKC isozymes are only partially understood. In this report, we show that PKCdelta mediates phorbol ester-induced G1 arrest in lung adenocarcinoma cells and establish an essential role for this novel PKC in controlling the expression of the cell cycle inhibitor p21. Activation of PKC with phorbol 12-myristate 13-acetate (PMA) in early G1 phase impaired progression of lung adenocarcinoma cells into S phase, an effect that was completely abolished by specific depletion of PKCdelta, but not PKCalpha. Although the PKC effect was unrelated to the inhibition of cyclin D1 expression, PKC activation significantly up-regulated p21 and down-regulated Rb hyperphosphorylation and cyclin A expression. Elevations in p21 mRNA and protein by PMA were mediated by PKCdelta but not PKCalpha. Studies using luciferase reporters also revealed an essential role for PKCdelta in the PMA-induced inhibition of Rb-dependent cyclin A promoter activity. Finally, we showed that the cell cycle inhibitory effect of PKCdelta is greatly attenuated by RNA interference-mediated knock-down of p21. Our results identify a novel link between PKCdelta and G1 arrest via p21 up-regulation and highlight the complexities in the downstream effectors of PKC isozymes in the context of cell cycle progression and proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055435     DOI: 10.1074/jbc.M505748200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Protein kinase Cα mediates erlotinib resistance in lung cancer cells.

Authors:  Mahlet B Abera; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2015-02-27       Impact factor: 4.436

2.  Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2.

Authors:  Bo Liu; Evan Joseph Ryer; Rishi Kundi; Kentaro Kamiya; Hiroyuki Itoh; Peter L Faries; Kenji Sakakibara; K Craig Kent
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

Review 3.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

4.  ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.

Authors:  Liqing Xiao; Masumi Eto; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2009-08-10       Impact factor: 5.157

Review 5.  Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.

Authors:  Mary E Reyland; David N M Jones
Journal:  Pharmacol Ther       Date:  2016-05-11       Impact factor: 12.310

6.  Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.

Authors:  John Meshki; M Cecilia Caino; Vivian A von Burstin; Erin Griner; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

7.  Tungsten-induced carcinogenesis in human bronchial epithelial cells.

Authors:  Freda Laulicht; Jason Brocato; Laura Cartularo; Joshua Vaughan; Feng Wu; Thomas Kluz; Hong Sun; Betul Akgol Oksuz; Steven Shen; Massimiliano Peana; Serenella Medici; Maria Antonietta Zoroddu; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2015-07-09       Impact factor: 4.219

8.  Structure-activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cells.

Authors:  Koji Wada; Masaharu Hazawa; Kenji Takahashi; Takao Mori; Norio Kawahara; Ikuo Kashiwakura
Journal:  J Nat Med       Date:  2010-08-14       Impact factor: 2.343

Review 9.  PKC signaling in glioblastoma.

Authors:  Anália do Carmo; Joana Balça-Silva; Diana Matias; Maria Celeste Lopes
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

10.  Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.

Authors:  K S Hill; E Erdogan; A Khoor; M P Walsh; M Leitges; N R Murray; A P Fields
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.